We Need Every Tool to End HIV

Matthew Murguia is a "PrEPer" and an HIV activist.

(Editor's Note: This blog has been cross-posted from Advocate.com. For more information on PrEP, visit AIDS.gov.)

HIV-negative gay men have a responsibility to use every tool at their disposal, including PrEP, to stay negative.

I'm a PrEPer.

FDA Approves First Combination Pill to Treat Hepatitis

Harvoni

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.

Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection. It is also the first approved regimen that does not require administration with interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection.

The Underlying Racism of Ebola Coverage

Hazmat

It's impossible to ignore the racist undertones in much of the world's Ebola coverage. Just yesterday, the United Nations huaman rights chief warned against anti-African discrimination over the disease. But it's already happening. Stassa Edwards over at Jezebel offers this:

USCA Black Treatment Advocates Network Preconference Takes Place in San Diego

Raniyah M. Copeland

On Oct. 1 the Black AIDS Institute held its Black Treatment Advocates Network (BTAN) preconference to the 2014 United States Conference on AIDS (USCA) in San Diego. Conducted by the National Minority AIDS Council (NMAC), the USCA, which is in its 18th year, took place Oct. 2-5.

In This Issue

Earlier this month the Institute held a pre-conference to the United States Conference on AIDS. Gerald Garth reports.

A recent study found that MSM and transgender women who took four or more doses of PrEP per week were able to prevent HIV acquisition. The Obama administration tells us that those of us who will use healthcare.gov when open enrollment begins next month should expect a faster website with a shorter application form and features making it easier to use on mobile devices.